LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

Home・Elenco Azioni・PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corp

Chiusa

SettoreSettore sanitario

22.58 -3.75

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

22.34

Massimo

22.67

Metriche Chiave
By Trading Economics
Entrata	-1.8M -21M
Vendite	4.1M 83M
Margine di Profitto	-25.695
Dipendenti	756
EBITDA	4.8M -19M

Raccomandazioni
By TipRanks
Raccomandazioni	Acquista
Previsioni per 12 mesi	+74.74% upside

Dividendi
By Dow Jones
Utili prossimi	23 apr 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-391M 1.5B
Apertura precedente	26.33
Chiusura precedente	22.58

Notizie sul Sentiment di mercato

By Acuity

100%

332 / 352 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

52.655 / 56.31 Supporto e resistenza

PROCEPT BioRobotics Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

27 feb 2026, 23:53 UTC

Azioni calde

Stocks to Watch: Aardvark Therapeutics, Blue Moon Metals

27 feb 2026, 22:23 UTC

Acquisizioni, Fusioni, Takeovers

Blue Moon Metals To Acquire Apex Germanium Mine From Teck Subsidiary

28 feb 2026, 21:36 UTC

Utili

Acquisizioni, Fusioni, Takeovers

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28 feb 2026, 15:20 UTC

Utili

Berkshire's Abel Pledges to Follow Buffett's 'Framework' in First Shareholder Letter -- 2nd Update

28 feb 2026, 14:43 UTC

Utili

Acquisizioni, Fusioni, Takeovers

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28 feb 2026, 14:38 UTC

Utili

Acquisizioni, Fusioni, Takeovers

Berkshire's Abel Pledges to Follow Buffett's 'Framework' in First Shareholder Letter -- Update

28 feb 2026, 13:47 UTC

Utili

Acquisizioni, Fusioni, Takeovers

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28 feb 2026, 13:44 UTC

Utili

Acquisizioni, Fusioni, Takeovers

Berkshire Hathaway Earnings Slip on Decline in Insurance Results -- WSJ

28 feb 2026, 13:14 UTC

Utili

Acquisizioni, Fusioni, Takeovers

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28 feb 2026, 02:32 UTC

Utili

Acquisizioni, Fusioni, Takeovers

Calpers Buys Into Hot Chip And Quantum Stocks -- Barrons.com

28 feb 2026, 02:00 UTC

Acquisizioni, Fusioni, Takeovers

Six Months, 9 Offers and $81 Billion. How Hollywood's Nasty Takeover Was Won. -- WSJ

28 feb 2026, 02:00 UTC

Acquisizioni, Fusioni, Takeovers

Six Months, 9 Offers and $81 Billion. How -2-

28 feb 2026, 00:01 UTC

Acquisizioni, Fusioni, Takeovers

Paramount Issuing $47 Billion of Equity at Big Premium to Stock Price for Warner Bros. Deal -- Barrons.com

27 feb 2026, 23:46 UTC

Acquisizioni, Fusioni, Takeovers

Netflix Walks Away a Winner After Losing Warner Bros. to Paramount -- Barrons.com

27 feb 2026, 23:33 UTC

Acquisizioni, Fusioni, Takeovers

Paramount Issuing $47 Billion of Equity at Nearly 20% Premium to Current Stock Price -- Barrons.com

27 feb 2026, 21:50 UTC

Discorsi di Mercato

Acquisizioni, Fusioni, Takeovers

Tech, Media & Telecom Roundup: Market Talk

27 feb 2026, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

27 feb 2026, 21:30 UTC

Utili

Solventum Beat Wall Street Earnings Estimates. The Stock Falls. -- Barrons.com

27 feb 2026, 21:30 UTC

Discorsi di Mercato

Acquisizioni, Fusioni, Takeovers

Warner Terminates Netflix Deal, Ending Monthslong Saga -- Market Talk

27 feb 2026, 21:20 UTC

Acquisizioni, Fusioni, Takeovers

Blue Moon Metals to Buy Apex Germanium and Gallium Mine From Teck >BMM

27 feb 2026, 21:17 UTC

Utili

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

27 feb 2026, 21:10 UTC

Acquisizioni, Fusioni, Takeovers

Blue Moon Metals Evaluating Options for a New Processing Line at Springer Complex to Process the Apex Material

27 feb 2026, 21:09 UTC

Acquisizioni, Fusioni, Takeovers

Blue Moon Metals to Acquire the Apex Germanium and Gallium Mine From Teck

27 feb 2026, 21:00 UTC

Utili

Nike: 3Q Results to Be Released March 31 to Accommodate for Several Holidays >NKE

27 feb 2026, 20:31 UTC

Acquisizioni, Fusioni, Takeovers

Netflix Receives $2.8B Termination Fee Under Terminated Warner Bros. Discovery Deal

27 feb 2026, 20:24 UTC

Discorsi di Mercato

Oil Gains on Increased Risk of U.S.-Iran Conflict -- Market Talk

27 feb 2026, 20:23 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Post Modest Gains -- Market Talk

27 feb 2026, 20:12 UTC

Discorsi di Mercato

Nike Seen With Further Challenges in China -- Market Talk

27 feb 2026, 19:44 UTC

Discorsi di Mercato

Gold Caps Historic Month -- Market Talk

27 feb 2026, 19:39 UTC

Utili

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

Confronto tra pari

Modifica del prezzo

PROCEPT BioRobotics Corp Previsione

Obiettivo di Prezzo

By TipRanks

74.74% in crescita

Previsioni per 12 mesi

Media 41.29 USD 74.74%

Alto 62 USD

Basso 20 USD

Basato su 10 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per PROCEPT BioRobotics Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

10 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 10 che hanno fornito valutazioni azionarie a PROCEPT BioRobotics Corp - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

52.655 / 56.31Supporto e resistenza

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.